Archived from the original on July 13, 2014
Muller DC, Giles GG, Sinclair R, Hopper JL, English DR, Severi G
Tirzepatide is a dual-action medication that goes beyond traditional GLP-1 therapy, and may produce stronger results for some men than semaglutide alone
For a scientific overview of the microbiome, the difference between GLP-1 agonist drugs and microbial approaches to regulating GLP-1, and the role GLP-1 plays in helping to maintain a healthy weight, please refer to the white paper: Harnessing GLP-1 in the digestive tract for better metabolic health
They should also have stable concurrent medications, with no recent changes to other glucose-lowering agents or medications affecting gastrointestinal function
Cristian Nelson Hear From Our Students & Families